Health Care [ 3/12 ] | Life Sciences Tools & Services [ 13/74 ]
NASDAQ | Common Stock
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.
The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services.
Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 18, 26 | 0.16 Increased by +700.00% | 0.57 Decreased by -71.93% |
| Feb 26, 26 | 0.09 Decreased by -50.00% | 0.53 Decreased by -83.02% |
| Nov 5, 25 | 0.12 Decreased by -47.83% | 0.48 Decreased by -75.00% |
| Aug 6, 25 | 0.19 Increased by +733.33% | 0.08 Increased by +137.50% |
| May 12, 25 | 0.02 Increased by +150.00% | -0.06 Increased by +134.90% |
| Mar 10, 25 | 0.18 Decreased by -5.26% | 0.37 Decreased by -50.73% |
| Nov 11, 24 | 0.23 Increased by +253.33% | 0.25 Decreased by -8.00% |
| Aug 12, 24 | -0.03 Decreased by -105.77% | 0.08 Decreased by -137.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 636.50 M Decreased by -2.27% | -23.60 M Increased by +95.81% | Decreased by -3.71% Increased by +95.71% |
| Dec 31, 25 | 660.50 M Decreased by -5.24% | -32.50 M Increased by +46.90% | Decreased by -4.92% Increased by +43.96% |
| Sep 30, 25 | 701.30 M Increased by +3.91% | -15.90 M Increased by +43.01% | Decreased by -2.27% Increased by +45.16% |
| Jun 30, 25 | 710.30 M Increased by +7.23% | -374.90 M Decreased by -170.88% | Decreased by -52.78% Decreased by -152.61% |
| Mar 31, 25 | 651.30 M Decreased by -1.63% | -562.90 M Decreased by -457.33% | Decreased by -86.43% Decreased by -466.57% |
| Dec 31, 24 | 697.00 M Decreased by -10.11% | -61.20 M Decreased by -70.00% | Decreased by -8.78% Decreased by -89.12% |
| Sep 30, 24 | 674.90 M Decreased by -5.45% | -27.90 M Decreased by -99.29% | Decreased by -4.13% Decreased by -110.77% |
| Jun 30, 24 | 662.40 M Decreased by -8.65% | -138.40 M Decreased by -549.35% | Decreased by -20.89% Decreased by -591.88% |